- Home
- YCBD vs POAI Comparison
YCBD vs POAI Comparison
Compare YCBD & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- POAI
- Stock Information
- Founded
- YCBD 2015
- POAI 2002
- Country
- YCBD United States
- POAI United States
- Employees
- YCBD N/A
- POAI N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- POAI Industrial Specialties
- Sector
- YCBD Health Care
- POAI Health Care
- Exchange
- YCBD Nasdaq
- POAI Nasdaq
- Market Cap
- YCBD 7.8M
- POAI 7.6M
- IPO Year
- YCBD N/A
- POAI N/A
- Fundamental
- Price
- YCBD $0.95
- POAI $0.80
- Analyst Decision
- YCBD Strong Buy
- POAI Hold
- Analyst Count
- YCBD 1
- POAI 1
- Target Price
- YCBD $3.00
- POAI N/A
- AVG Volume (30 Days)
- YCBD 67.8K
- POAI 206.9K
- Earning Date
- YCBD 08-13-2025
- POAI 08-12-2025
- Dividend Yield
- YCBD N/A
- POAI N/A
- EPS Growth
- YCBD N/A
- POAI N/A
- EPS
- YCBD N/A
- POAI N/A
- Revenue
- YCBD $19,593,146.00
- POAI $1,729,269.00
- Revenue This Year
- YCBD $13.00
- POAI $486.27
- Revenue Next Year
- YCBD $10.00
- POAI $65.50
- P/E Ratio
- YCBD N/A
- POAI N/A
- Revenue Growth
- YCBD N/A
- POAI 24.17
- 52 Week Low
- YCBD $0.76
- POAI $0.55
- 52 Week High
- YCBD $6.54
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- YCBD 51.65
- POAI 39.89
- Support Level
- YCBD $0.90
- POAI $0.75
- Resistance Level
- YCBD $0.99
- POAI $0.82
- Average True Range (ATR)
- YCBD 0.06
- POAI 0.05
- MACD
- YCBD 0.01
- POAI 0.01
- Stochastic Oscillator
- YCBD 58.90
- POAI 52.66
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.